(24) found that ALKBH5 was closely related to the poor prognosis of Non-Small Cell Lung Cancer (NSCLC), and ALKBH5 affected the progression of NSCLC by inhibiting the stability and protein synthesis of TIMP3. This evidence concerns the gene ALKBH5 and non-small cell lung carcinoma.